The Simcyp Pediatric Simulator was used to model exposure in children and adolescents, simulate DDIs, and provide dose recommendations. Dose adjustments for moderate to severe CYP3A4 inhibitors and inducers were determined using the physiologically-based pharmacokinetic (PBPK) modeling as described in the label.